Clinical Trial Update: Smog Induced Indoor Air Pollution in Homes of Chronic Obstructive Pulmonary Disease Patients.

View source ↗

Summary

This clinical trial investigating smog-induced indoor air pollution in homes of COPD patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Chronic Obstructive Pulmonary Disease | Status: WITHDRAWN